Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico

被引:0
作者
Amen Ben Hamida
Claudia Rafful
Sonia Jain
Shelly Sun
Patricia Gonzalez-Zuniga
Gudelia Rangel
Steffanie A. Strathdee
Dan Werb
机构
[1] University of California San Diego,Division of Global Public Health
[2] San Diego State University,Graduate School of Public Health
[3] University of California San Diego,Department of Family Medicine and Public Health, Biostatistics Research Center
[4] Secretariat of Health,undefined
[5] Mexico-United States Border Health Commission,undefined
[6] Centre for Urban Health Solutions,undefined
[7] St. Michael’s Hospital,undefined
[8] University of California School of Medicine,undefined
来源
Journal of Urban Health | 2018年 / 95卷
关键词
Injection initiation; Injection drug use; People who inject drugs; Non-injection drug use; Tijuana; Border health; Prevention;
D O I
暂无
中图分类号
学科分类号
摘要
Although most people who inject drugs (PWID) report receiving assistance during injection initiation events, little research has focused on risk factors among PWID for providing injection initiation assistance. We therefore sought to determine the influence of non-injection drug use among PWID on their risk to initiate others. We used generalized estimating equation (GEE) models on longitudinal data among a prospective cohort of PWID in Tijuana, Mexico (Proyecto El Cuete IV), while controlling for potential confounders. At baseline, 534 participants provided data on injection initiation assistance. Overall, 14% reported ever initiating others, with 4% reporting this behavior recently (i.e., in the past 6 months). In a multivariable GEE model, recent non-injection drug use was independently associated with providing injection initiation assistance (adjusted odds ratio [AOR] = 2.42, 95% confidence interval [CI] = 1.39–4.20). Further, in subanalyses examining specific drug types, recent non-injection use of cocaine (AOR = 9.31, 95% CI = 3.98–21.78), heroin (AOR = 4.00, 95% CI = 1.88–8.54), and methamphetamine (AOR = 2.03, 95% CI = 1.16–3.55) were all significantly associated with reporting providing injection initiation assistance. Our findings may have important implications for the development of interventional approaches to reduce injection initiation and related harms. Further research is needed to validate findings and inform future approaches to preventing entry into drug injecting.
引用
收藏
页码:83 / 90
页数:7
相关论文
共 134 条
[11]  
Montaner JS(2000)Correlates of HIV infection among young adult short-term injection drug users AIDS 14 717-339
[12]  
Kerr T(2014)Interrupting the social processes linked with initiation of injection drug use: results from a pilot study Drug Alcohol Depend 137 48-573
[13]  
Milloy MJ(2006)Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico Subst Use Misuse 41 707-676
[14]  
Kerr T(2005)HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana J Psychoactive Drugs 37 333-293
[15]  
Tyndall M(2008)Mexico’s evolving HIV epidemic JAMA 300 571-1196
[16]  
Montaner J(2013)Interventions to prevent the initiation of injection drug use: a systematic review Drug Alcohol Depend 133 669-494
[17]  
Wood E(2007)The gendered context of initiation to injecting drug use: evidence for women as active initiates Drug Alcohol Rev. 26 287-192
[18]  
Werb D(1996)The first hit: circumstances surrounding initiation into injecting Addiction 91 1187-890
[19]  
Garfein R(2014)Transition to injection drug use: the role of initiators AIDS Behav 18 486-1575
[20]  
Kerr T(2007)My first time: initiation into injecting drug use in Manipur and Nagaland, north-east India Harm Reduct J 4 19-596